Preliminary reports indicate conolidine may well inhibit unique ion channels, decreasing neuronal excitability and limiting suffering signals. This mechanism is especially relevant in neuropathic discomfort, in which abnormal signaling causes persistent pain. Additionally, conolidine appears to impact G protein-coupled receptor (GPCR) pathways integral to suffering notion. Computation... https://jamest580xto0.ourabilitywiki.com/user